製品名:Bis(2,2,2-trifluoroethyl)carbonate (TFEC)

IUPAC Name:

CAS番号:1513-87-7
分子式:C5H4F6O3
純度:95%+
カタログ番号:CM000259
分子量:226.07

包装単位 有効在庫 価格(USD) 数量
CM000259-10g 3-4 Weeks ſƋƋ
CM000259-25g 3-4 Weeks DzƋƋ
CM000259-100g 5-6 Weeks ȌƋſȱ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1513-87-7
分子式:C5H4F6O3
融点:-
SMILESコード:O=C(OCC(F)(F)F)OCC(F)(F)F
密度:
カタログ番号:CM000259
分子量:226.07
沸点:
MDL番号:MFCD11857845
保管方法:

Category Infos

Lithium-ion Battery Materials
Lithium-ion batteries (Li-ion batteries) are widely used in portable electronic devices, electric vehicles, and renewable energy storage systems due to their high energy density and long cycle life. These batteries are composed of several key materials such as cathode materials, anode materials, electrolyte, separator and current collector, which enable them to operate. Other minor components in Li-ion batteries include binders, additives, and fillers, which improve electrode stability, electrolyte performance, and battery safety. Ongoing research and development focus on improving the energy density, safety, and cost-effectiveness of Li-ion batteries through advancements in materials, including the exploration of new cathode and anode materials, solid-state electrolytes, high-voltage electrolyte additives, and advanced manufacturing techniques.

Column Infos

Inavolisib
Genentech’s Phase III results show that the Inavolisib (GDC-0077) treatment meets the primary end point in hormone receptor (HR)-positive, HER2-negative, PIK3CA-mutated Breast Cancer. The combination of Inavolisib with Palbociclib and fulvestrant improves the progression-free survival (PFS) in the first line. Inavolisib is a potent selective inhibitor of PI3K alpha (PI3Kα) that binds to the ATP-binding site of p110α, and promotes the degradation of mutated p110α.

Related Products